Tibion is a privately held company

Tibion is a privately held company developing innovative equipment that can help individuals recover physical function lost due to disease, trauma or aging.

Its first commercialized product, the Tibion Bionic Leg, actively assists therapists with the rehabilitation of individuals who present with lower extremity dysfunction that impairs function, mobility and gait. Primary candidates for the Tibion Bionic Leg include individuals disabled by stroke, and certain neurologic degenerative diseases such as multiple sclerosis.

The company began marketing the Bionic Leg in January 2010. Customers span the U.S., from New England to the San Francisco Bay area.

The Tibion management team is led by CEO Charles Remsberg, an executive with nearly 20 years of experience managing the successful commercialization of high-technology rehabilitation equipment. The Tibion board of directors includes professionals and investors with decades of experience managing and building medical technology and service organizations.